A recent study indicates that individuals who stop using new weight-loss injections like Wegovy and Mounjaro can put back on lost weight far faster than those who stop conventional lifestyle regimens.
Published data in a leading health publication demonstrates that while obese individuals frequently drop about a fifth of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing such treatments must be aware of the danger of rapid rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb.
That rate of regain implies a return to original weight within about 18 months.
Weighing Therapies
The study, which reviewed dozens of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with other pills.
Scientists point out that people who shed pounds through lifestyle changes alone generally see a slower creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Nutrition scientists believe the mode of action of the drugs explains the accelerated weight return.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal might result in the system to produce less of its own natural hormone, and could reduce responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating much more probable."
An Ongoing Condition?
Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by recommended diet and exercise modifications.
Many experts contend that, considering the likelihood of relapse, the therapy might need to be ongoing.
This view is echoed by pharmaceutical companies, who state that the results "emphasize the persistent character of obesity," akin to managing diseases like diabetes.
User Experiences
Individuals who have come off the jabs explain a intense return of appetite.
"It was like a switch activating and you're instantly extremely hungry," said an individual.
This difficulty is worsened if users have not developed lasting lifestyle or habit changes during treatment.
Growing Interest
Recent estimates suggest that a significant number of people in the UK have used these injections in the past year, with interest being substantial.
- Adoption is greater among females than men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while GLP-1 drugs are effective agents for weight loss, they are not a magic fix and maintained weight loss hinges on ongoing lifestyle support.
